These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31419311)

  • 1. Severe hypersensitivity reactions to biological drugs in children with rheumatic diseases.
    Soyer O; Demir S; Bilginer Y; Batu ED; Sonmez HE; Arıcı ZS; Şahiner ÜM; Sekerel BE; Ozen S
    Pediatr Allergy Immunol; 2019 Dec; 30(8):833-840. PubMed ID: 31419311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.
    Demir S; Soyer O; Bilginer Y; Sag E; Sahiner UM; Buyuktiryaki B; Sekerel BE; Ozen S
    Clin Exp Rheumatol; 2020; 38(3):552-557. PubMed ID: 31820716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years' experience of a tertiary pediatric rheumatology center.
    Koç R; Sönmez HE; Çakan M; Karadağ ŞG; Tanatar A; Çakmak F; Aktay Ayaz N
    Rheumatol Int; 2020 May; 40(5):771-776. PubMed ID: 31865444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety.
    Al-Mayouf SM; Alenazi A; AlJasser H
    Int J Rheum Dis; 2016 Jun; 19(6):600-5. PubMed ID: 24730661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Hypersensitivity Reactions in Pediatric Patients Using Biological Drugs.
    Yilmaz Topal O; Kose V; Acar B; Bayrakci US; Ozyoruk D; Hizal G; Karaatmaca B; Toyran M; Yarali HN; Ozbek NY; Dibek Misirlioğlu E
    Int Arch Allergy Immunol; 2021; 182(9):844-851. PubMed ID: 34082429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylaxis to tocilizumab in patients with rheumatic disease.
    Nam SH; Lim DH; Heo HM; Oh JS; Kwon HS; Kim TB; Ahn SM; Hong S; Lee CK; Yoo B; Kim YG
    Immunotherapy; 2021 Dec; 13(18):1483-1489. PubMed ID: 34657472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis.
    Yun H; Xie F; Beyl RN; Chen L; Lewis JD; Saag KG; Curtis JR
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1526-1534. PubMed ID: 27813327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity Reactions to Monoclonal Antibodies in Children.
    Mori F; Saretta F; Bianchi A; Crisafulli G; Caimmi S; Liotti L; Bottau P; Franceschini F; Paglialunga C; Ricci G; Santoro A; Caffarelli C
    Medicina (Kaunas); 2020 May; 56(5):. PubMed ID: 32408641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of drug-induced anaphylaxis in children and adolescents.
    Cavkaytar O; Karaatmaca B; Cetinkaya PG; Esenboga S; Arik Yilmaz E; Sahiner UM; Sekerel BE; Soyer O
    Allergy Asthma Proc; 2017 Sep; 38(5):56-63. PubMed ID: 28814352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse and Hypersensitivity Reactions to Prescription Nonsteroidal Anti-Inflammatory Agents in a Large Health Care System.
    Blumenthal KG; Lai KH; Huang M; Wallace ZS; Wickner PG; Zhou L
    J Allergy Clin Immunol Pract; 2017; 5(3):737-743.e3. PubMed ID: 28110055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
    Spoerl D; Nigolian H; Czarnetzki C; Harr T
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Hypersensitivity Reactions Documented in Electronic Health Records within a Large Health System.
    Wong A; Seger DL; Lai KH; Goss FR; Blumenthal KG; Zhou L
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1253-1260.e3. PubMed ID: 30513361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of self-reported drug hypersensitivity reactions among Lithuanian children and adults.
    Kvedariene V; Sitkauskiene B; Tamasauskiene L; Rudzeviciene O; Kasiulevicius V; Nekrosyte G; Gomes ER; Demoly P
    Allergol Immunopathol (Madr); 2019; 47(1):32-37. PubMed ID: 30245285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests.
    Ponvert C; Perrin Y; Bados-Albiero A; Le Bourgeois M; Karila C; Delacourt C; Scheinmann P; De Blic J
    Pediatr Allergy Immunol; 2011 Jun; 22(4):411-8. PubMed ID: 21535179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity reactions to antiepileptic drugs in children.
    Atanasković-Marković M; Janković J; Tmušić V; Gavrović-Jankulović M; Ćirković Veličković T; Nikolić D; Škorić D
    Pediatr Allergy Immunol; 2019 Aug; 30(5):547-552. PubMed ID: 30951222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Antibodies Hypersensitivity: Prevalence and Management.
    Santos RB; Galvão VR
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):695-711. PubMed ID: 28965635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty Years' Experience with Anaphylaxis-Like Reactions to Local Anesthetics: Genuine Allergy is Rare.
    Trautmann A; Goebeler M; Stoevesandt J
    J Allergy Clin Immunol Pract; 2018; 6(6):2051-2058.e1. PubMed ID: 29655774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actual drug allergy during childhood: Five years' experience at a tertiary referral centre.
    Tugcu GD; Cavkaytar O; Sekerel BE; Sackesen C; Kalayci O; Tuncer A; Soyer O
    Allergol Immunopathol (Madr); 2015; 43(6):571-8. PubMed ID: 25963806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Risk of Oxaliplatin-Induced Hypersensitivity in Patients with Asymptomatic Prior Exposure: A Prospective Observational Study.
    Sohn KH; Kang DY; Kim JY; Lee SY; Lee KH; Han SW; Kang HR
    J Allergy Clin Immunol Pract; 2018; 6(5):1642-1648.e2. PubMed ID: 29454708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Risk Factors of Immediate Hypersensitivity Reactions Associated With Low-Osmolar Iodinated Contrast Media: A Longitudinal Study Based on a Real-Time Monitoring System.
    Lee SY; Kang DY; Kim JY; Yoon SH; Choi YH; Lee W; Cho SH; Kang HR
    J Investig Allergol Clin Immunol; 2019; 29(6):444-450. PubMed ID: 30676320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.